CVS Health Price to Sales

CVS Health Corporation -- USA Stock  

USD 61.50  0.29  0.47%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
CVS Health 
MV Per Share 
Revenue Per Share 
0.36 times

Distress Driver Correlations

 CVS Health Price to Sales Ratio 

About Price to Sales

The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition

CVS Health Price to Sales Assessment


CVS Health Sales Growth Over Time

Price to Sales Ratio

Return on Sales

Based on latest financial disclosure the price to sales indicator of CVS Health Corporation is roughly 0.36 times. This is 98.32% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Services industry, The Price to Sales for all stocks is 97.98% higher than the company.

Peer Comparison

CVS Health Price to Sales Comparison
CVS Health is rated below average in price to sales category among related companies.

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
Hide  View All  NextLaunch Portfolio Manager